CRP 검사(C 반응성 단백 검사) 시장 : 어세이 유형별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

C-reactive Protein Testing Market, By Assay Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

US $ 3,250 ￦ 4,702,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,728,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 8,174,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

리포트 하이라이트

CRP 검사(C 반응성 단백 검사) 시장 규모는 2023년에 56억 3,300만 달러에 달하고, 2024-2032년 CAGR 1.5%로 성장할 것으로 예측되고 있습니다.

CRP 검사 시장 - 시장 역학

CVD 유병률 증가로 시장 수요 증가

세계보건기구(WHO)에 따르면 심혈관 질환은 전 세계 사망의 주요 원인 중 하나이며, C 반응성 단백질은 심장마비 및 뇌졸중 발생 가능성을 예측하는 데 매우 유용한 툴로, C 반응성 단백질은 동맥경화 위험을 측정하기 때문에 CVD를 발견할 수 있는 신뢰할 수 있는 지표가 될 수 있습니다. 가 됩니다. 동맥에 플라크가 쌓이면 동맥벽 내부에 염증이 생겨 동맥경화증으로 알려진 상태가 됩니다. 이에 따라 신속하고 효과적인 진단 기술의 필요성이 높아지면서 심혈관 질환을 확인하기 위한 CRP 검사의 활용이 가속화되고 있습니다. 또한 예측 기간 중 심혈관 질환에서 CRP의 기능에 대한 지속적인 연구가 진행되면서 시장 매출 성장을 가속화할 것으로 예상됩니다.

CRP 검사 시장 - 주요 인사이트

• 리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 1.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
• 분석 유형별 세분화에 따르면 예측 기간 중 면역 비탁도 분석 부문이 시장을 지배할 것으로 예상됩니다.
• 용도별로 보면 예측 기간 중 심혈관 질환 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
• 지역별로는 북미가 예측 기간 중 시장을 독점할 것으로 예상됩니다.

CRP 검사 시장 - 세분화 분석 :

• 세계 CRP 검사 시장은 분석 유형, 애플리케이션 및 지역에 따라 세분화됩니다.
• 분석 유형에 따라 CRP 검사 시장은 화학 발광 면역 분석법(CLIA), 효소 결합 면역 흡착 분석법(ELISA), 면역 비등도 분석법 및 기타로 나뉩니다. 면역비말측정법 부문은 예측 기간 중 시장을 지배할 것으로 예상됩니다. 광범위한 CRP 수준을 평가할 수 있는 우수한 민감도를 가진 저렴한 가격의 자동 면역비말측정법이 개발되어 사용 가능해짐에 따라 이 부문의 매출 성장을 가속할 것으로 예상됩니다. 임상 생화학에서는 CRP와 전신 염증 및 동맥경화 위험의 지표인 CRP와 고감도 CRP를 일상적으로 분석했습니다. 또한 면역 비탁도 측정법에 대한 연구개발 증가는 장기적으로 이 부문의 매출 개발을 더욱 촉진할 것으로 예상됩니다.
• 용도에 따라 CRP 검사 산업은 심혈관 질환, 염증성 장 질환, 당뇨병, 류마티스 관절염 및 기타로 분류됩니다. 예측 기간 중 심혈관 질환 분야가 가장 큰 시장 점유율을 차지할 것으로 예상되며, CVD 유병률 증가는 CRP 검사 시장의 성장을 이끄는 주요 요인이며, 동맥경화 위험을 측정하여 CVD를 진단하는 중요한 마커 및 지표로 작용할 것으로 예상됩니다. 심혈관 질환(CVD) 환자는 CRP 수치가 상승하는 경우가 많으며, CRP 검사는 매우 낮은 CRP 수치로도 식별할 수 있습니다. 따라서 예측 기간 중 이 분야의 매출 성장은 심혈관 질환 식별을 위한 CRP 검사의 사용량이 눈에 띄게 증가함에 따라 주도될 것입니다.

CRP 검사 시장 - 지역적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다. 예측 기간 중 북미가 시장을 지배할 것으로 예상됩니다. 이 부문의 우위는 심혈관 질환 이환율 증가, 제품 출시 증가, 기존 비즈니스의 존재, 기술 개선, 잘 정비된 의료 인프라 등 여러 가지 요인에 기인하는 것으로 보입니다. 또한 미국 루즈벨트대학교 약학대학이 2020년 9월 Frontiers in Immunology지에 발표한 'How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression'라는 연구 결과에 따르면 Disease Progression'이라는 제목의 연구에 따르면 CRP 검사의 기능적 생리활성은 수십년간 거의 정의되지 않은 전형적인 급성기 반응 물질로, 다양한 증상과 질환의 진단에 CRP 혈중 농도가 진행 중인 염증의 단적인 지표로 사용되어 왔습니다. 이번 연구로 인해 CRP 검사를 통해 체내 염증을 진단하는 사람들이 더욱 늘어날 것으로 보입니다.

CRP 검사 시장 - 경쟁 구도 :

시장에 참여하고 있는 주요 기업 : Quest Diagnostics Incorporated, Thermo Fisher Scientific, Abbott Laboratories, Zoetis Inc(Abaxis Inc.), Randox Laboratories Limited, F. Hoffmann-La Roche AG, Danaher Corporation(Beckman Coulter Inc.), Merck KGAA(Millipore Sigma), Horiba, Ltd., Laboratory Corporation of America Holdings 등

목차

제1장 CRP 검사 시장 개요

• 조사 범위
• 시장 추정 연수

제2장 주요 요약

• 시장 내역
• 경쟁 인사이트

제3장 CRP 검사의 주요 시장 동향

• 시장 촉진요인
• 시장 억제요인
• 시장 기회
• 향후 시장 동향

제4장 CRP 검사 업계의 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 매핑
• 규제 구조의 분석

제5장 CRP 검사 시장 : COVID-19의 영향 분석

• COVID-19 이전의 영향 분석
• COVID-19 이후의 영향 분석

제6장 CRP 검사 시장 구도

• CRP 검사 시장 점유율 분석, 2023년
• 주요 제조업체별 내역 데이터
  • 기존 기업의 분석
  • 신규 기업의 분석

제7장 CRP 검사 시장 : 어세이 유형별

• 개요
  • 부문 점유율 분석 : 어세이 유형별
  • 화학 발광 면역측정법(CLIA)
  • 효소 결합 면역흡착 검정법(ELISA)
  • 면역비탁 어세이
  • 기타

제8장 CRP 검사 시장 : 용도별

• 개요
  • 부문 점유율 분석 : 용도별
  • 순환기 질환
  • 염증성장질환
  • 당뇨병
  • 류마티스 관절염
  • 기타

제9장 CRP 검사 시장 : 지역별

• 서론
• 북미
  • 개요
  • 북미의 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조업체
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아태평양(APAC)
  • 개요
  • 아시아태평양의 주요 제조업체
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 라틴아메리카
  • 개요
  • 라틴아메리카의 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제10장 주요 벤더 분석 : CRP 검사 업계

• 경쟁 대시보드
• 기업 개요
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Zoetis Inc.(Abaxis Inc.)
  • Randox Laboratories Limited
  • F. Hoffmann-La Roche AG
  • Danaher Corporation(Beckman Coulter Inc.)
  • Merck KGAA(Millipore Sigma)
  • Horiba, Ltd.
  • Laboratory Corporation of America Holdings

제11장 애널리스트의 전방위 전망

KSA

영문 목차

영문목차

REPORT HIGHLIGHT

C-reactive Protein Testing Market size was valued at USD 5,633 Million in 2023, expanding at a CAGR of 1.5% from 2024 to 2032.

An acute-phase protein called C-reactive protein (CRP) is created by the liver and is released into the bloodstream in response to inflammatory conditions. The level of CRP in blood plasma is measured using the c-reactive protein (CRP) test.

C-reactive Protein Testing Market- Market Dynamics

Increasing prevalence of CVD to propel market demand

According to the World Health Organization, cardiovascular disease is one of the main causes of mortality globally. C-reactive protein is a very useful tool for predicting a person's chance of having a heart attack or stroke. C-reactive protein measures the risk of atherosclerosis, making it a reliable marker for CVD detection. Plaque accumulation inside the arteries causes inflammation inside the artery walls, a condition known as atherosclerosis. This has increased the need for prompt and effective diagnosis techniques, which has sped up the use of CRP testing to identify cardiovascular disease. Furthermore, during the forecast period, it is anticipated that continued research into the function of C-reactive protein in cardiovascular illnesses would accelerate market revenue growth.

C-reactive Protein Testing Market- Key Insights

• As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 1.5% over the forecast period (2024-2032)

• Based on assay type segmentation, the Immunoturbidimetric assays segment is expected to dominate the market during the forecast period

• Based on application segmentation, the cardiovascular disease segment is expected to hold the largest market share over the forecast period

• Based on region, North America is expected to dominate the market over the forecast period

C-reactive Protein Testing Market- Segmentation Analysis:

• The Global C-reactive Protein Testing Market is segmented based on Assay Type, Application, and Region.

• Based on the assay type, the C-reactive Protein Testing market is divided into Chemiluminescence Immunoassay (CLIA), Enzyme-linked immunosorbent assay (ELISA), Immunoturbidimetric assays and Others. The Immunoturbidimetric assays segment is expected to dominate the market during the forecast period. The development and availability of affordable automated immunoturbidimetric assays with excellent sensitivity for assessing a broad range of CRP levels is anticipated to drive the segment's revenue growth. Clinical biochemistry routinely analyses CRP and high-sensitivity CRP using these tests, which are markers of systemic inflammation and atherosclerosis risk. Furthermore, it is projected that the growing research efforts concerning immunoturbidimetric assays will further bolster this segment's revenue development over the long run.

• Based on the application, the C-reactive Protein Testing industry is categorized into Cardiovascular Disease, Inflammatory Bowel Disease, Diabetes, Rheumatoid Arthritis and Others. The Cardiovascular Disease segment is expected to hold the largest market share over the forecast period. An increase in the prevalence of CVDs is the key factor leading to the growth of the CRP testing market acts as a vital marker and indication for diagnosing CVDs by measuring the risk of atherosclerosis. Patients with cardiovascular diseases (CVDs) frequently have elevated CRP levels, and tests can identify even very low CRP levels. As a consequence, throughout the projection period, the revenue growth of this sector will be driven by the notable increase in the usage of CRP testing for the identification of cardiovascular illnesses.

C-reactive Protein Testing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. This segment's dominance is probably due to a number of factors, including increased cardiovascular disease incidence, increasing product releases, the existence of established businesses, technical improvements, and a well-developed healthcare infrastructure. Furthermore, a study by Roosevelt University College of Pharmacy in the United States published in Frontiers in Immunology in September 2020 titled "How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression" states that because the functional bioactivity of the CRP test-which has been a largely undefined prototypical acute phase reactant for decades-diagnostics of a wide range of conditions and diseases use CRP blood levels as a straightforward indicator of ongoing inflammation. These investigations will encourage more people to use CRP testing to diagnose inflammation in the body.

C-reactive Protein Testing Market- Competitive Landscape:

The key players operating in the market are: Quest Diagnostics Incorporated, Thermo Fisher Scientific, Inc., Abbott Laboratories, Zoetis Inc. (Abaxis Inc.), Randox Laboratories Limited, F. Hoffmann-La Roche AG, Danaher Corporation (Beckman Coulter Inc.), Merck KGAA (Millipore Sigma), Horiba, Ltd. and Laboratory Corporation of America Holdings among others.

Recent Developments:

In January 2022, LumiraDx's C-reactive protein PCR test received CE mark certification. This microfluidic immunoassay test is small, lightweight, completely automated, and can detect C-reactive protein quantitatively in as little as four minutes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL C-REACTIVE PROTEIN TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Quest Diagnostics Incorporated

• Thermo Fisher Scientific, Inc.

• Abbott Laboratories

• Zoetis Inc. (Abaxis Inc.)

• Randox Laboratories Limited

• F. Hoffmann-La Roche AG

• Danaher Corporation (Beckman Coulter Inc.)

• Merck KGAA (Millipore Sigma)

• Horiba, Ltd.

• Laboratory Corporation of America Holdings

GLOBAL C-REACTIVE PROTEIN TESTING MARKET, BY ASSAY TYPE- MARKET ANALYSIS, 2019 - 2032

• Chemiluminescence Immunoassay (CLIA)
• Enzyme-linked immunosorbent assay (ELISA)
• Immunoturbidimetric assays
• Others

GLOBAL C-REACTIVE PROTEIN TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Cardiovascular Disease
• Inflammatory Bowel Disease
• Diabetes
• Rheumatoid Arthritis
• Others

GLOBAL C-REACTIVE PROTEIN TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
  • The U.S.
  • Canada

• Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe

• Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC

• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

• The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. C-reactive Protein Testing Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. C-reactive Protein Testing Market Snippet by Assay Type
  • 2.1.2. C-reactive Protein Testing Market Snippet by Application
  • 2.1.3. C-reactive Protein Testing Market Snippet by Country
  • 2.1.4. C-reactive Protein Testing Market Snippet by Region
• 2.2. Competitive Insights

3. C-reactive Protein Testing Key Market Trends

• 3.1. C-reactive Protein Testing Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. C-reactive Protein Testing Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. C-reactive Protein Testing Market Opportunities
• 3.4. C-reactive Protein Testing Market Future Trends

4. C-reactive Protein Testing Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. C-reactive Protein Testing Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. C-reactive Protein Testing Market Landscape

• 6.1. C-reactive Protein Testing Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. C-reactive Protein Testing Market - By Assay Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Assay Type, 2023 & 2032 (%)
  • 7.1.2. Chemiluminescence Immunoassay (CLIA)
  • 7.1.3. Enzyme-linked immunosorbent assay (ELISA)
  • 7.1.4. Immunoturbidimetric assays
  • 7.1.5. Others

8. C-reactive Protein Testing Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2. Cardiovascular Disease
  • 8.1.3. Inflammatory Bowel Disease
  • 8.1.4. Diabetes
  • 8.1.5. Rheumatoid Arthritis
  • 8.1.6. Others

9. C-reactive Protein Testing Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. C-reactive Protein Testing Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. C-reactive Protein Testing Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.7. Italy
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.7.3. Italy Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.3.7.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.8. United Kingdom
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.8.3. United Kingdom Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.9. France
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.9.3. France Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.10. Russia
    • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.10.2. Russia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.3.10.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.11. Netherlands
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.11.2. Netherlands Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.12. Sweden
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.12.2. Sweden Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.13. Poland
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.13.2. Poland Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.3.13.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.14. Rest of Europe
    • 9.3.14.1. Overview
    • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. C-reactive Protein Testing Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.8. Japan
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.8.3. Japan Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.9. South Korea
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.9.3. South Korea Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. C-reactive Protein Testing Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. C-reactive Protein Testing Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- C-reactive Protein Testing Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. Quest Diagnostics Incorporated
  • 10.2.2. Thermo Fisher Scientific, Inc.
  • 10.2.3. Abbott Laboratories
  • 10.2.4. Zoetis Inc. (Abaxis Inc.)
  • 10.2.5. Randox Laboratories Limited
  • 10.2.6. F. Hoffmann-La Roche AG
  • 10.2.7. Danaher Corporation (Beckman Coulter Inc.)
  • 10.2.8. Merck KGAA (Millipore Sigma)
  • 10.2.9. Horiba, Ltd.
  • 10.2.10. Laboratory Corporation of America Holdings

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us

관련자료